92 results
8-K
EX-99.1
ARVN
Arvinas, Inc.
16 May 24
Regulation FD Disclosure
6:05am
. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has four investigational
8-K
EX-99.1
5zmnbvc ff
7 May 24
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:02am
8-K
EX-99.1
5sgnp 3c77f7
11 Apr 24
Entry into a Material Definitive Agreement
7:03am
8-K
EX-99.1
aknnry8t
27 Feb 24
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:02am
S-3ASR
v98mxdotd6nw
8 Dec 23
Automatic shelf registration
9:16am
8-K
EX-99.1
gehtusr
6 Dec 23
Regulation FD Disclosure
7:01am
8-K
EX-99.1
czjmoetzao
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
S-3ASR
p1or8q0x tp
7 Nov 23
Automatic shelf registration
5:24pm
8-K
EX-99.1
vu21m45 ar
7 Nov 23
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
cnazbft6 k2dh
23 Oct 23
Regulation FD Disclosure
8:30am
8-K
EX-99.2
x5hhk38vm78w
23 Oct 23
Regulation FD Disclosure
8:30am